Steven Hansel

1.1k total citations
29 papers, 683 citations indexed

About

Steven Hansel is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Steven Hansel has authored 29 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Steven Hansel's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Drug Transport and Resistance Mechanisms (6 papers) and HIV Research and Treatment (4 papers). Steven Hansel is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Drug Transport and Resistance Mechanisms (6 papers) and HIV Research and Treatment (4 papers). Steven Hansel collaborates with scholars based in United States, Germany and France. Steven Hansel's co-authors include Chang Cheng, Shaorong Liu, Deqing Xiao, Xiaogang Han, Tracey Clark, L. Nathan Tumey, Cong Wei, Frank Barletta, Brian Rago and Marilyn E. Morris and has published in prestigious journals such as Analytical Chemistry, Journal of Pharmacology and Experimental Therapeutics and Journal of Pharmaceutical Sciences.

In The Last Decade

Steven Hansel

29 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Hansel United States 14 200 166 160 123 122 29 683
Wenyu Wu China 20 470 2.4× 107 0.6× 165 1.0× 67 0.5× 55 0.5× 62 1.1k
Yan Guan China 16 598 3.0× 94 0.6× 89 0.6× 35 0.3× 81 0.7× 26 1.0k
Changdev G. Gadhe South Korea 15 340 1.7× 135 0.8× 48 0.3× 54 0.4× 32 0.3× 48 608
Pat Wheelan United States 17 402 2.0× 134 0.8× 63 0.4× 42 0.3× 58 0.5× 39 863
Joan D. Ellis United States 14 129 0.6× 71 0.4× 98 0.6× 28 0.2× 132 1.1× 19 483
Marina Tintelnot‐Blomley Switzerland 17 463 2.3× 71 0.4× 197 1.2× 24 0.2× 222 1.8× 29 879
Amy Q. Wang United States 17 390 1.9× 225 1.4× 149 0.9× 17 0.1× 34 0.3× 31 1.1k
Richard A. Nugent United States 15 289 1.4× 112 0.7× 312 1.9× 37 0.3× 29 0.2× 26 897
Fisayo A. Olotu South Africa 18 439 2.2× 106 0.6× 73 0.5× 22 0.2× 36 0.3× 79 857
Ragini Vuppugalla United States 16 214 1.1× 304 1.8× 90 0.6× 39 0.3× 39 0.3× 27 898

Countries citing papers authored by Steven Hansel

Since Specialization
Citations

This map shows the geographic impact of Steven Hansel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Hansel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Hansel more than expected).

Fields of papers citing papers by Steven Hansel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Hansel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Hansel. The network helps show where Steven Hansel may publish in the future.

Co-authorship network of co-authors of Steven Hansel

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Hansel. A scholar is included among the top collaborators of Steven Hansel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Hansel. Steven Hansel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Hanwen, et al.. (2024). Identifying biomarkers for treatment of uveal melanoma by T cell engager using a QSP model. npj Systems Biology and Applications. 10(1). 108–108. 4 indexed citations
2.
Wang, Hanwen, et al.. (2023). Using quantitative systems pharmacology modeling to optimize combination therapy of anti-PD-L1 checkpoint inhibitor and T cell engager. Frontiers in Pharmacology. 14. 1163432–1163432. 11 indexed citations
3.
Kenny, Cynthia Hess, Zheng Cai, Angus W. MacDonald, et al.. (2022). Development of novel ultra-sensitive IL-11 target engagement assays to support mechanistic PK/PD modeling for an anti-IL-11 antibody therapeutic. mAbs. 14(1). 2104153–2104153. 3 indexed citations
4.
Wang, Jun, Craig Giragossian, & Steven Hansel. (2021). Analyze impact of tumor-associated kinetics on antibody delivery in solid tumors with a physiologically based pharmacokinetics/pharmacodynamics model. European Journal of Pharmaceutics and Biopharmaceutics. 168. 110–121. 4 indexed citations
5.
Wei, Cong, Guodong Zhang, Tracey Clark, et al.. (2016). Where Did the Linker-Payload Go? A Quantitative Investigation on the Destination of the Released Linker-Payload from an Antibody-Drug Conjugate with a Maleimide Linker in Plasma. Analytical Chemistry. 88(9). 4979–4986. 68 indexed citations
6.
Yeung, Kap‐Sun, Zhilei Qiu, Zheng Yang, et al.. (2012). Inhibitors of HIV-1 attachment. Part 9: An assessment of oral prodrug approaches to improve the plasma exposure of a tetrazole-containing derivative. Bioorganic & Medicinal Chemistry Letters. 23(1). 209–212. 35 indexed citations
7.
Qiu, Zhilei, Haiquan Fang, Zheng Yang, et al.. (2012). Inhibitors of HIV-1 attachment. Part 7: Indole-7-carboxamides as potent and orally bioavailable antiviral agents. Bioorganic & Medicinal Chemistry Letters. 23(1). 198–202. 46 indexed citations
8.
Cheng, Chang, et al.. (2010). LC–MS/MS method development and validation for the determination of polymyxins and vancomycin in rat plasma. Journal of Chromatography B. 878(28). 2831–2838. 66 indexed citations
9.
Zheng, Ming, John M. Lubinski, Oliver Flint, et al.. (2009). Studies on the pharmacokinetics and metabolism of a γ-secretase inhibitor BMS-299897, and exploratory investigation of CYP enzyme induction. Xenobiotica. 39(7). 544–555. 3 indexed citations
10.
Yang, Zheng, Lisa Zadjura, Anthony M. Marino, et al.. (2009). Utilization of in vitro Caco‐2 permeability and liver microsomal half‐life screens in discovering BMS‐488043, a novel HIV‐1 attachment inhibitor with improved pharmacokinetic properties. Journal of Pharmaceutical Sciences. 99(4). 2135–2152. 16 indexed citations
11.
Bergstrom, Carl P., C.P. Sloan, David W. Smith, et al.. (2007). Carbamate-appended N-alkylsulfonamides as inhibitors of γ-secretase. Bioorganic & Medicinal Chemistry Letters. 18(2). 464–468. 9 indexed citations
12.
Wittman, Mark D., Balu Balasubramanian, Upender Velaparthi, et al.. (2006). Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase. Bioorganic & Medicinal Chemistry Letters. 17(4). 974–977. 19 indexed citations
13.
Yang, Zheng, Lisa Zadjura, Celia D’Arienzo, et al.. (2005). Preclinical pharmacokinetics of a novel HIV‐1 attachment inhibitor BMS‐378806 and prediction of its human pharmacokinetics. Biopharmaceutics & Drug Disposition. 26(9). 387–402. 22 indexed citations
14.
Barten, Donna M., Valerie Guss, Jason A. Corsa, et al.. (2005). Dynamics of β-Amyloid Reductions in Brain, Cerebrospinal Fluid, and Plasma of β-Amyloid Precursor Protein Transgenic Mice Treated with a γ-Secretase Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 312(2). 635–643. 118 indexed citations
15.
Williams, J. Andrew, Jonathan Bauman, Hongliang Cai, et al.. (2005). In vitro ADME phenotyping in drug discovery: current challenges and future solutions.. PubMed. 8(1). 78–88. 12 indexed citations
16.
Prasad, C. V. C., C.P. Sloan, Michael F. Parker, et al.. (2004). Hydroxytriamides as potent γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(8). 1917–1921. 19 indexed citations
17.
Mastalerz, Harold, Craig R. Fairchild, Steven Hansel, et al.. (2003). The discovery of BMS-275183: an orally efficacious novel taxane. Bioorganic & Medicinal Chemistry. 11(20). 4315–4323. 39 indexed citations
18.
19.
Saulnier, Mark G., David B. Frennesson, Milind Deshpande, Steven Hansel, & Dolatrai M. Vyas. (1994). An efficient method for the synthesis of guanidino prodrugs. Bioorganic & Medicinal Chemistry Letters. 4(16). 1985–1990. 7 indexed citations
20.
Morris, Marilyn E. & Steven Hansel. (1990). High-performance liquid chromatographic analysis of p-nitrophenol and its conjugates in biological samples. Journal of Chromatography B Biomedical Sciences and Applications. 532(2). 285–293. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenyu Wu Breakdown of academic impact, for papers by Yan Guan Breakdown of academic impact, for papers by Changdev G. Gadhe Breakdown of academic impact, for papers by Pat Wheelan Breakdown of academic impact, for papers by Joan D. Ellis Breakdown of academic impact, for papers by Marina Tintelnot‐Blomley Breakdown of academic impact, for papers by Amy Q. Wang Breakdown of academic impact, for papers by Richard A. Nugent Breakdown of academic impact, for papers by Fisayo A. Olotu Breakdown of academic impact, for papers by Ragini Vuppugalla
Rankless by CCL
2026